Copyright
©The Author(s) 2023.
World J Clin Cases. Sep 16, 2023; 11(26): 6200-6205
Published online Sep 16, 2023. doi: 10.12998/wjcc.v11.i26.6200
Published online Sep 16, 2023. doi: 10.12998/wjcc.v11.i26.6200
Figure 2 Summary of the absolute neutrophil counts from initiating vincristine, prednisolone, daunorubicin, and l-asparaginase therapy to the end of the second venetoclax/decitabine cycle.
VDPL: Vincristine, prednisolone, daunorubicin, and l-asparaginase.
- Citation: Park S, Jeong EJ, Kang JH, Lee GW, Go SI, Lee DH, Koh EH. T/myeloid mixed-phenotype acute leukemia treated with venetoclax and decitabine: A case report. World J Clin Cases 2023; 11(26): 6200-6205
- URL: https://www.wjgnet.com/2307-8960/full/v11/i26/6200.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i26.6200